Port Washington, NY 1/12/10—Pall has acquired MicroReactor Technologies for an undisclosed amount. MicroReactor Technologies provides a miniature bioreactor platform for process development and fermentation, which is reliable, easy to use and cost effective, according to Pall. The company’s High Throughput Process Development (HTPD) systems control, monitor and record process parameter for multiple individual cell culture experiments in one test sequence. According to Pall, HTPD enables drug development that is faster and uses less material. MicroReactor Technologies’ platform simulates the performance of stirred tank bioreactors in cell culture and microbial fermentation from bench to larger scale. “Customers seek better tools for rapid process development and process monitoring,” stated Pall Chairman and CEO Eric Krasnoff. “The addition of MRT further broadens Pall Life Sciences support of customers in this rapidly growing market.”